Remdesivir,
Exploring its Safety and Efficacy
Al Ritter
Remdesivir was manufactured by Gilead Sciences under
the brand name Veklury. Its intended use was for treatment of Ebola and Hepatitis
C in 2019 shortly before the Covid-19 outbreak.
In double blind randomly controlled trials Remdesivir
was tested in conjunction with 3 other medicines for its efficacy against
Ebola. Just 28 days into the trials it found that two of the four treatments
were killing the test subjects, the most deadly one was Remdesivir that killed
close to 50% of the patients. It was recommended that the two treatments be
withdrawn. Subsequently the trials for Hepatitis C didn’t fare much better.
Gilead Sciences was now stuck with a product and no disease to use it on.
We aren’t speaking yet about Covid this discussion so
far is about safety. The safety statements were made in the New England Journal
of Medicine and also in the NIH transcripts of the same trials.
Enter The Covid-19 response especially from the FDA
and CDC and the NIAID. All these agencies knew about the dangers of Remdesivir
and yet they were prepared to use it in *off label* use in treatment for
Covid-19. The off label use part was intentionally used to force home the idea
that the very same thing that those agencies claim about how Ivermectin can’t
be used off label is now the very same thing they are doing with Remdesivir.
The FDA approved the EUA for Remdesivir based on a
study supplied to them by Gilead Sciences of less than 1000 participants with
no blind study group, making this study totally useless.
On the other hand The World Health Organization was
doing their own “Solidarity Trials” that included 11,000 participants WITH
control groups. In November 2020 after their study was done, they found no discernable
difference in time of hospitalization or efficacy in the treatment of Covid-19
and therefore highly discouraged the use of Remdesivir.
Sadly the WHO never did a safety study on the drug
only efficacy.
In Gilead Sciences own description of Remdesivir they
speak to the danger to critical organs from its use. Some doctors say that
renal failure is a byproduct of Covid-19 itself, and other scuff at the idea.
But what does remain is that when used for treatment for Ebola almost 50% of
the participants that used Remdesivir died from renal failure. Understand this
was a year prior to the Covid-19 outbreak, so those deaths couldn’t be blamed
on Covid!
Here's some food for thought. If you were told that you had a 99.97% chance of recovery from a disease through normal avenues, but then you were offered a drug that kills 50% of it's recipients once infected.....would you then see that drug as 50% effective? This is our government's logic folks wake the hell up!
It seems suspect to me not only how such a dangerous
drug can stay on the market, but why would our government groups approve this
drug for off label use when it’s efficacy and safety are in question.
I don’t understand their thinking when their own
studies prove something different.
And just last week the FDA has approved under the EUA outpatient use of Remdesivir on adults and children weighing as little as 8 lb!
Read all my research here:
https://www.forbes.com/sites/jvchamary/2021/01/31/remdesivir-covid-coronavirus/?sh=c3aef0c66c27
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250494/
New England Journal of Medicine:
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910993?articleTools=true
https://kystandsup.org/remdesivir/
3 comments:
The government will not tell you how many people this drug has killed already!
One only has to google the word to see how deadly it is
This crap killed one of my family members also!
Post a Comment